№ files_lp_4_process_3_065798
File format: docx
Character count: 2269
File size: 22 KB
Analysis of HCV diagnostic screening prevalence and confirmatory testing among PWID in a national surveillance study.
Year:
2013
Region / City:
Australia
Topic:
Hepatitis C Virus Screening
Document Type:
Research Study / Surveillance Report
Institution:
The Kirby Institute; Western Australia Department of Health; Queensland Health; Australian Injecting & Illicit Drug Users League; Tasmanian Department of Health and Human Services
Authors:
J. Iversen, J. Bevan, R. Kemp, A. Madden, F. Smith, L. Maher
Target Population:
People Who Inject Drugs (PWID)
Data Source:
Australian Needle and Syringe Program Survey (ANSPS)
Methodology:
Self-reported diagnostic screening, multivariable logistic regression
Key Findings:
Screening uptake, RNA/genotype testing rates, factors associated with testing
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Authors:
Woodall H; Mukandavire C; Martin NK; Goldberg D; Palmateer N; Munro A; Taylor A; Hickman M; Hutchinson S; Vickerman P
Affiliated Institutions:
University of Bristol; University of California, San Diego; Glasgow Caledonian University; Health Protection Scotland; University of the West of Scotland
Country:
Scotland, United Kingdom
Study Period:
2008–2015
Topic:
Hepatitis C virus transmission among people who inject drugs
Type of Document:
Scientific research article
Data Source:
Needle Exchange Surveillance Initiative (NESI)
Interventions Examined:
Opiate substitution therapy (OST); Needle and syringe programmes (NSP); HCV treatment; Reduction in high-risk behaviour
Methodology:
Dynamic transmission modelling with calibration to national surveillance data
Key Findings:
Estimated 64% reduction in HCV incidence between 2008 and 2015; approximately 900 infections averted by OST/NSP scale-up; additional reductions linked to behavioural changes and treatment
Geographical Focus:
Scotland
Year:
2010-2024
Region / city:
Asia-Pacific
Subject:
Hepatology
Document Type:
Clinical Practice Guidelines
Organization / Institution:
Asian Pacific Association for the Study of the Liver (APASL)
Author:
APASL
Target Audience:
Healthcare professionals
Period of validity:
2010-2024
Date of approval:
2010
Date of revisions:
2024
Context:
Collection of clinical practice guidelines and consensus statements issued by the Asian Pacific Association for the Study of the Liver on various hepatological conditions, including hepatocellular carcinoma, hepatitis B and C, liver transplantation, and metabolic diseases.
Year:
2026
Region:
United States
Document Type:
Policy Procedure
Organization:
Public Housing Agency (PHA)
Programs:
Public Housing (PH), Project-Based Voucher (PBV), Housing Choice Voucher (HCV)
Subject:
Interim Rent Adjustments
Effective Date:
Specified per adjustment section
Applicable Regulations:
24 CFR § 5.630, § 960.253(f)
Target Audience:
Residents participating in PH, PBV, or HCV programs
Year:
2012
Region / City:
Ukraine
Topic:
HCV treatment access, harm reduction, public health policy
Document Type:
Research paper
Organization / Institution:
Alliance
Author:
Ludmila Maistat, Pavlo Skala, Tatiana Barnard, Nataliia Kravchenko
Target Audience:
Public health professionals, policymakers, medical community
Period of Action:
2012 and ongoing
Date of Approval:
Not specified
Date of Changes:
Not specified
Description:
This document details the outcomes of large-scale advocacy and demonstration treatment programs aimed at improving access to HCV treatment for people who inject drugs (PWIDs) in Ukraine, with a focus on policy changes and the integration of HCV treatment into harm reduction programs.
Year:
2014
Region / city:
Calgary, Alberta, Canada
Theme:
Hepatitis C, Healthcare Outreach
Document type:
Research report
Organization / institution:
University of Calgary, CUPS
Author:
Macphail GLP, Watson LJ, Edwards RL
Target audience:
Healthcare professionals, Public health workers, Community health organizations
Period of validity:
2014 - present
Approval date:
Not specified
Date of changes:
Not specified
Contextual description:
A research report documenting the implementation of Fibroscan Days to increase patient engagement and improve access to care for Hepatitis C in an inner-city health centre.
Year:
2026
Region / City:
South West London, United Kingdom
Topic:
Hepatitis C, liver health, peer support
Document Type:
Job description
Organization:
The Hepatitis C Trust
Position:
Peer Support Lead
Reporting To:
South West London Peer Coordinator
Work Base:
Home-based, regional outreach
Hours per Week:
37.5
Key Responsibilities:
Peer education, workforce development, buddy scheme, blood borne virus testing, liver health promotion
Target Audience:
Community outreach workers, people who inject drugs, marginalised populations
Relevant Projects:
Follow Me Project, Community Liver Health Bus, Community Liver Surveillance Project
Required Skills:
Peer support, training delivery, communication with healthcare and community services, administrative duties
Year:
2023
Note:
Region / City
Subject:
Billing Requirements for Drugs and Biologicals with Discarded Amounts
Document Type:
Policy
Organization / Institution:
SummaCare, Apex Summa Health Management Company, Summa Insurance Company
Target Audience:
Providers, Healthcare Administrators, Claims Department
Effective Period:
From 01/01/2017
Approval Date:
08/15/2023
Review Date:
Every 2 years or as necessary
Compliance Statement:
All members of the workforce are responsible for compliance with this policy.
Monitoring and Auditing:
Claims Department
Documentation Retention:
Minimum of 10 years
Purpose:
To outline the billing requirements for drugs and biologicals with unused and discarded amounts from single-dose containers or single-use packages.
Description:
Guidelines on proper billing procedures for drugs and biologicals, including the use of JW and JZ modifiers for discarded drug amounts or no wastage in single-dose vials, applicable to providers and insurers.
Year:
2025
Region / City:
Not specified
Theme:
Healthcare, Drug Coverage
Document Type:
Informational Flyer
Organization / Institution:
Wellcare
Author:
Not specified
Target Audience:
Healthcare providers, insurance plan members
Period of Validity:
Not specified
Approval Date:
07/24/2024
Date of Changes:
Not specified
Year:
2021
Region / City:
Australia
Theme:
Mental health, Alcohol and Other Drugs
Document Type:
Unit of competency
Organization / Institution:
Australian Skills Quality Authority (ASQA)
Author:
Not specified
Target Audience:
People working in community services, mental health and alcohol and other drug sectors
Period of validity:
Not specified
Approval Date:
Not specified
Date of modifications:
Release 2, Modification History: Release 2
Note:
Year
Topic:
Clinical Trial Agreement
Document Type:
Contract
Institution / Organization:
Istituto clinico Humanitas
Target Audience:
Medical, Scientific, and Research Professionals
Unit code:
CHCAOD007
Release:
2
Type:
Competency unit
Sector:
Health and community services
Target group:
Workers supporting people with alcohol and other drug challenges
Application:
Relapse prevention and management strategies
Legislation and standards:
Commonwealth and State/Territory legislation, Australian/New Zealand standards, industry codes of practice
Skills:
Relapse prevention planning, risk assessment, harm minimisation, communication, crisis management
Assessment:
Workplace demonstration or simulated environment, treatment plans, risk assessment tools
Knowledge:
Legal and ethical considerations, AOD effects and responses, relapse triggers, support strategies, therapy options, environmental and individual risk factors
Year:
2023
Region:
Scotland
Jurisdiction:
Scotland
Topic:
Management of controlled drugs in primary care
Document type:
Guidance
Version:
3.0
Publication date:
April 2023
Issuing body:
Controlled Drugs Accountable Officers’ Network Scotland
Contributing organisation:
NHS Dumfries & Galloway
Foreword author:
Graeme Bryson
Author role:
Director of Pharmacy
Target audience:
Practitioners working within primary care
Legal framework referenced:
Misuse of Drugs Act 1971; Misuse of Drugs Regulations 2001; Controlled Drugs (Supervision of Management and Use) Regulations 2013
Scope:
Prescribing, supply, administration, storage, recording, monitoring and destruction of controlled drugs
Source type:
Official professional guidance
Note:
Year
Topic:
Incident Reporting
Document Type:
Report Form
Organization:
NHS
Target Audience:
NHS Staff, Contractors
Year:
2023
Region / City:
Southwest London
Theme:
Pharmaceutical Offers, Medicines Access
Document Type:
Template
Organization / Institution:
Southwest London Integrated Care System (SWL ICS)
Author:
Southwest London ICS Pharmacy Team
Target Audience:
Healthcare Professionals, Pharmacists, Medical Staff
Action Period:
Ongoing
Approval Date:
2023-10-01
Amendment Date:
N/A
Contextual Description:
A template outlining procedures for Southwest London Trusts to request approval for commercial offers and deeply discounted medicines, including "Free of Charge" (FOC) schemes based on RMOC guidelines.
Year:
2012
Region / City:
Morgan County, Georgia
Topic:
Legal procedure, DUI test evidence
Document type:
Court brief
Organ / Institution:
Superior Court of Morgan County, Georgia
Author:
N/A
Target Audience:
Legal professionals, court officials
Period of validity:
N/A
Approval date:
N/A
Date of changes:
N/A
Year:
2019
Region / City:
Victoria, Australia
Topic:
Forensic Alcohol and Other Drugs (AOD) Treatment Services
Document Type:
Government Publication
Organization:
Victorian Government
Author:
Department of Health and Human Services (DHHS) and Department of Justice and Community Safety (DJCS)
Target Audience:
Service providers, professionals in the AOD and correctional sectors
Period of Validity:
Ongoing
Approval Date:
June 2019
Date of Changes:
Not specified
Year:
2017
Region / City:
United States
Theme:
Public Law, Pharmaceutical Pricing
Document Type:
Request for Modification
Organization / Institution:
U.S. Department of Veterans Affairs
Author:
Not specified
Target Audience:
Contractors in the pharmaceutical and medical supply industry
Effective Period:
January 15, 2017 or later
Approval Date:
November 2016
Amendment Date:
November 2016
Context:
A regulatory document outlining the procedures for modifying contracts related to pharmaceutical pricing under Public Law 102-585.
Year:
2023
Region / City:
Portland
Topic:
Clinical Research
Document Type:
Form
Author:
VA Portland Health Care System
Target Audience:
Researchers, Investigators, IRB Members
Period of Action:
Ongoing
Approval Date:
Not specified
Modification Date:
Not specified